Skin Analytics is a UK-based medical AI company, founded in 2012, that builds autonomous AI for skin cancer detection. Its main product, DERM, is a Class III CE-marked AI medical device that assesses dermoscopic images of skin lesions and decides whether a patient can be safely discharged or needs to see a specialist. It is mostly used in NHS urgent suspected skin cancer pathways, backed by the company’s own teledermatology platform for dermatologist review. DERM Zero, launched in June 2026, brings the same technology to smartphone photos, so primary care and community providers can run checks without a dermoscope. The vendor reports more than 40 NHS partners and over 250,000 patient assessments. It is built for NHS trusts, health systems and insurers rather than individual clinicians. Pricing is not publicly listed; interested organizations are directed to contact the team or book a demo.

Helping more people survive skin cancer

Key features

DERM autonomous triage: assesses dermoscopic images of lesions only and directs each case to discharge or specialist review; Class III CE-marked AI medical device
DERM Zero smartphone assessment: location photo plus close-up photo in a smartphone app, with an autonomous decision (discharge or route to specialist pathway); no dermoscope needed
Imaging clinic pathway: consent, history and dermoscopic images captured after a GP urgent referral, before the AI assessment
Teledermatology platform: captures patient data and supports virtual dermatologist review of higher-risk cases; hosted in the UK
Automatic fallback: lesions unsuitable for DERM (e.g. ulcerated or under the nails) are routed to a dermatologist
Locked model: DERM does not self-learn; updates are released manually through the regulatory pathway
Post-market surveillance: ongoing performance monitoring, including subgroup analysis across skin types (Fitzpatrick I-VI)

Strengths

Only Class III CE-marked AI medical device for skin cancer (vendor claim)
40+ NHS partners and 250,000+ patient assessments (vendor figures)
Independent evaluations cited, including an NHS England-commissioned Edge Health report and a University of Surrey/Unity Insights evaluation
ISO 13485 and ISO 27001 certified
DERM Zero removes the need for dermoscopy equipment

Best for

NHS trust dermatology lead managing urgent suspected skin cancer referral backlogs
ICB or regional health system commissioner building community skin cancer pathways
Private health insurer wanting autonomous skin cancer triage
Primary care, pharmacy or community provider offering skin checks (DERM Zero)

skin-analytics.com

Skin Analytics

Key features

Strengths

Best for

Categories

Features

Add Review

Leave a Reply Cancel reply

Added By Maylana